ATAD2 and non-small cell lung carcinoma: Variations in ATAD2 in smokers were found in non-small cell lung cancer (NSCLC) patients, and ATAD2 amplification not only regulates MYC-dependent transcription but is also a major driver of MYC-promoting lung adenocarcinoma cell proliferation [46].